Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Free Radic Biol Med ; 30(10): 1067-77, 2001 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-11369496

RESUMO

Retinoic acid (RA) has already been shown to exert antiapoptotic and antioxidative activity in various cells. In this study, we determined the effect of RA on the mRNA and protein levels of the Cu-,Zn-superoxide dismutase (SOD-1) and Mn-superoxide dismutase (SOD-2) during staurosporine-induced apoptosis in primary cultures from neonatal rat hippocampus. Exposure to staurosporine (300 nM, 24 h) increased the percentage of apoptotic neurons to 62% compared with 18% in controls. We determined an increase in the reactive oxygen species (ROS) content from 4 up to 48 h after the induction of the injury. Treatment with staurosporine did not significantly change the mRNA levels of SOD-1 and SOD-2. However, the SOD-1 and SOD-2 protein levels markedly decreased 24 and 48 h after the addition of staurosporine. Compared with staurosporine-exposed controls, RA (10 nM)-treated cultures showed a significant increase in neuronal survival, a reduced neuronal ROS content, and enhanced protein levels of SOD-1 and SOD-2 24 and 48 h after the start of the exposure to staurosporine. The results suggest that RA reduced staurosporine-induced oxidative stress and apoptosis by preventing the decrease in the protein levels of SOD-1 and SOD-2, and thus supported the antioxidant defense system.


Assuntos
Apoptose/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Superóxido Dismutase/metabolismo , Tretinoína/farmacologia , Animais , Animais Recém-Nascidos , Western Blotting , Células Cultivadas , Hipocampo/citologia , Hipocampo/efeitos dos fármacos , Hipocampo/enzimologia , Hipocampo/metabolismo , Microscopia de Fluorescência , Neurônios/efeitos dos fármacos , Neurônios/enzimologia , Neurônios/metabolismo , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Ratos , Ratos Endogâmicos F344 , Espécies Reativas de Oxigênio/metabolismo , Estaurosporina/antagonistas & inibidores , Estaurosporina/farmacologia , Superóxido Dismutase/genética , Superóxido Dismutase-1
2.
Neurochem Int ; 38(3): 227-35, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11099781

RESUMO

The effect of TGF-beta1 on apoptosis varies depending on the cell type, the kind of stimulus and the experimental conditions. The present study attempted to identify whether TGF-beta1 can prevent neuronal apoptosis and interrupt caspase-3 activation in rat primary hippocampal cultures after staurosporine treatment. TGF-beta1 at the concentration of 1 and 10 ng/ml significantly reduced neuronal damage as detected by trypan blue exclusion. Nuclear staining with Hoechst 33258 and TUNEL-staining further demonstrated that TGF-beta1 at the same concentration range effectively diminished neuronal apoptosis 24 h after staurosporine treatment, whereas 0.1 ng/ml of TGF-beta1 did not. Furthermore, TGF-beta1 (1 and 10 ng/ml) markedly inhibited the activation of caspase-3 induced by staurosporine as demonstrated by both caspase-3 activity assay and Western blotting. This study provides evidence that TGF-beta1 is able to efficiently inhibit caspase-3 activation, and thereby protects cultured hippocampal neurons against apoptosis.


Assuntos
Apoptose/efeitos dos fármacos , Inibidores de Caspase , Hipocampo/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Fator de Crescimento Transformador beta/farmacologia , Animais , Western Blotting , Caspase 3 , Caspases/metabolismo , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Relação Dose-Resposta a Droga , Ativação Enzimática/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Fluorometria , Hipocampo/citologia , Hipocampo/enzimologia , Marcação In Situ das Extremidades Cortadas , Neurônios/citologia , Neurônios/enzimologia , Ratos , Ratos Endogâmicos F344 , Estaurosporina/farmacologia , Fator de Crescimento Transformador beta1
3.
J Neurosci ; 20(15): 5715-23, 2000 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-10908611

RESUMO

An increased production of superoxide has been shown to mediate glutamate-induced neuron death. We monitored intracellular superoxide production of hippocampal neurons during and after exposure to the glutamate receptor agonist NMDA (300 microm). During a 30 min NMDA exposure, intracellular superoxide production increased significantly and remained elevated for several hours after wash-out of NMDA. After a 5 min exposure, superoxide production remained elevated for 10 min, but then rapidly returned to baseline. Mitochondrial membrane potential also recovered after wash-out of NMDA. However, recovery of mitochondria was transient and followed by delayed mitochondrial depolarization, loss of cytochrome c, and a secondary rise in superoxide production 4-8 hr after NMDA exposure. Treatment with a superoxide dismutase mimetic before the secondary rise conferred the same protection against cell death as a treatment before the first. The secondary rise could be inhibited by the complex I inhibitor rotenone (in combination with oligomycin) and mimicked by the complex III inhibitor antimycin A. To investigate the relationship between cytochrome c release and superoxide production, human D283 medulloblastoma cells deficient in mitochondrial respiration (rho(-) cells) were exposed to the apoptosis-inducing agent staurosporine. Treatment with staurosporine induced mitochondrial release of cytochrome c, caspase activation, and cell death in control and rho(-) cells. However, a delayed increase in superoxide production was only observed in control cells. Our data suggest that the delayed superoxide production in excitotoxicity and apoptosis occurs secondary to a defect in mitochondrial electron transport and that mitochondrial cytochrome c release occurs upstream of this defect.


Assuntos
Grupo dos Citocromos c/metabolismo , Mitocôndrias/enzimologia , Neurônios/citologia , Neurotoxinas/metabolismo , Superóxidos/metabolismo , Animais , Apoptose/efeitos dos fármacos , Apoptose/fisiologia , Transporte de Elétrons/fisiologia , Complexo III da Cadeia de Transporte de Elétrons/metabolismo , Elétrons , Agonistas de Aminoácidos Excitatórios/farmacologia , Sequestradores de Radicais Livres/farmacologia , Ácido Glutâmico/metabolismo , Hipocampo/citologia , Humanos , Meduloblastoma , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/fisiologia , Metaloporfirinas/farmacologia , Mitocôndrias/efeitos dos fármacos , N-Metilaspartato/farmacologia , Neurônios/enzimologia , Ratos , Ratos Endogâmicos F344 , Espécies Reativas de Oxigênio/metabolismo , Superóxido Dismutase/metabolismo , Células Tumorais Cultivadas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA